NSCLC

Test Your Knowledge

Quiz: What Combo Therapy Yields Benefit in Patients with EGFR Mutated Advanced NSCLC?

08/03/2021

The combination of first-generation EGFR-TKIs and ______ achieves a satisfactory PFS, ORR, DCR, and well-tolerated toxicity in advanced NSCLC patients with EGFR mutations.

The combination of...

08/03/2021

Oncology

News

EGFR-TKIs Exhibit Safety and Tolerability in Patients with NSCLC

07/22/2021

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in combination with chemotherapy were studied for safety variables in patients with advanced non-small-cell lung cancer (NSCLC) and sensitive EGFR mutations.

Epidermal growth factor...

07/22/2021

Oncology

News

Higher Out-of-Pocket Costs Associated With Decreased TKI Adherence in NSCLC

02/15/2021

Journal of Clinical Pathways

News

Timely Specialty Palliative Care for NSCLC Associated With Cost-Savings

12/17/2020

Journal of Clinical Pathways

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End of Life

06/14/2017

JCP Editors

Aggressive care in the last month of life for patients with non–small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care. Patients with advanced NSCLC who are nearing...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Chemo After Surgery Improves OS in Patients With NSCLC and Brain Metastasis

06/03/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) and synchronous brain metastasis demonstrate improved 1-year and 5-year overall survival (OS) after thoracic surgery and systemic chemotherapy, according to research...

...

06/03/2017

Journal of Clinical Pathways

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End-of-Life

05/26/2017

JCP Editors

Aggressive care within the last month of life for patients with non-small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care, according to new research. ----- Related...

...

05/26/2017

Journal of Clinical Pathways

Research in Review

Study Shows Low Adherence to Guidelines for Brain Imaging in NSCLC Patients

10/28/2015

JCP Editors

As part of the Choosing Wisely® campaign, the Society of Thoracic Surgeons developed a list of tests and procedures that they consider to be ordered more often than necessary. Included in this list is the use of...

As...

10/28/2015

Journal of Clinical Pathways

Research in Review

Improved Outcomes for NSCLC Patients with Immunotherapy versus Chemotherapy

10/15/2015

JCP Editors

Researchers from the University of Texas-Southwest Medical Center compared the immunotherapy drug nivolumab with a commonly used chemotherapy drug and found that it improved overall survival with...

...

10/15/2015

Journal of Clinical Pathways